Voyager Therapeutics' low P/S ratio may be due to anticipate...

Voyager Therapeutics' low P/S ratio may be due to anticipated poor growth or falling revenue. The company's shrinking revenue outlook is contributing to its low P/S. Without significant change, a drastic rise in stock price is hard to foresee.